Neurocrine Biosciences
NBIX
#1518
Rank
$11.79 B
Marketcap
$119.16
Share price
-1.16%
Change (1 day)
-15.22%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2025 (TTM): $0.53 Billion USD

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are $2.41 Billion USD. In 2024 the company made an earning of $0.61 Billion USD, an increase over its 2023 earnings that were of $0.31 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $0.53 B-13.32%
2024 $0.61 B96.41%
2023 $0.31 B41.13%
2022 $0.22 B73.74%
2021 $0.12 B-8.82%
2020 $0.13 B77.78%
2019 $78.46 M49.83%
2018 $52.37 M-142.57%
2017 -$0.13 Billion-14.73%
2016 -$0.15 Billion53.15%
2015 -$94.21 Million46.25%
2014 -$64.42 Million29.66%
2013 -$49.68 Million-3530.8%
2012 $1.44 M-95.73%
2011 $33.92 M
2009 -$47.69 Million-45.38%
2008 -$87.3 Million-58.87%
2007 -$0.22 Billion87.3%
2006 -$0.12 Billion351.97%
2005 -$25.08 Million-52.09%
2004 -$52.34 Million-10.98%
2003 -$58.79 Million
2001 -$43.89 Million
1999 -$19.79 Million108.32%
1998 -$9.5 Million
1996 $2.9 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$1.84 Million-100.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.01 B 279.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$26.94 Million-105.07%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.60 B 2,461.28%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.71 B 599.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.34 B 1,847.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$22.22 Million-104.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-$41.77 Million-107.86%๐Ÿ‡บ๐Ÿ‡ธ USA